Literature DB >> 14764895

The limits of protection by "memory" T cells in Ig-/- mice persistently infected with a gamma-herpesvirus.

Samita Andreansky1, Haiyan Liu, Heiko Adler, Ulrich H Koszinowski, Stacey Efstathiou, Peter C Doherty.   

Abstract

Can CD4(+) and CD8(+) "memory" T cells that are generated and maintained in the context of low-level virus persistence protect, in the absence of antibody, against a repeat challenge with the same pathogen? Although immune T cells exert effective, long-term control of a persistent gamma-herpesvirus (gammaHV68) in Ig(-/-) microMT mice, subsequent exposure to a high dose of the same virus leads to further low-level replication in the lung. This lytic phase in the respiratory tract is dealt with effectively by the recall of memory T cells induced by a gammaHV68 recombinant (M3LacZ) that does not express the viral M3 chemokine binding protein. At least for the CD8(+) response, greater numbers of memory T cells confer enhanced protection in the M3LacZ-immune mice. However, neither WT gammaHV68 nor the minimally persistent M3LacZ primes the T cell response to the extent that a WT gammaHV68 challenge fails to establish latency in the microMT mice. Memory CD4(+) and CD8(+) T cells thus act together to limit gammaHV68 infection but are unable to provide absolute protection against a high-dose, homologous challenge.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764895      PMCID: PMC357044          DOI: 10.1073/pnas.0307320101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

Review 1.  The importance of gamma delta T cells in the resolution of pathogen-induced inflammatory immune responses.

Authors:  S R Carding; P J Egan
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

2.  Virus reconstituted from infectious bacterial artificial chromosome (BAC)-cloned murine gammaherpesvirus 68 acquires wild-type properties in vivo only after excision of BAC vector sequences.

Authors:  H Adler; M Messerle; U H Koszinowski
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus.

Authors:  S R Sarawar; B J Lee; S K Reiter; S P Schoenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

4.  Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus.

Authors:  M Y Sangster; D J Topham; S D'Costa; R D Cardin; T N Marion; L K Myers; P C Doherty
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

Review 5.  Natural history of murine gamma-herpesvirus infection.

Authors:  A A Nash; B M Dutia; J P Stewart; A J Davison
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

Review 6.  Dissecting the host response to a gamma-herpesvirus.

Authors:  P C Doherty; J P Christensen; G T Belz; P G Stevenson; M Y Sangster
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

7.  T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.

Authors:  L Liu; E J Usherwood; M A Blackman; D L Woodland
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Immunological control of a murine gammaherpesvirus independent of CD8+ T cells.

Authors:  P G Stevenson; R D Cardin; J P Christensen; P C Doherty
Journal:  J Gen Virol       Date:  1999-02       Impact factor: 3.891

9.  Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice.

Authors:  G T Belz; P G Stevenson; M R Castrucci; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

10.  A broad spectrum secreted chemokine binding protein encoded by a herpesvirus.

Authors:  C M Parry; J P Simas; V P Smith; C A Stewart; A C Minson; S Efstathiou; A Alcami
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  8 in total

1.  Clearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-gamma but not B cells, CD8+ T cells, or perforin.

Authors:  Sherri L Surman; Scott A Brown; Bart G Jones; David L Woodland; Julia L Hurwitz
Journal:  AIDS Res Hum Retroviruses       Date:  2010-07       Impact factor: 2.205

2.  CD8(+) T cells from mice transnuclear for a TCR that recognizes a single H-2K(b)-restricted MHV68 epitope derived from gB-ORF8 help control infection.

Authors:  Sharvan Sehrawat; Oktay Kirak; Paul-Albert Koenig; Marisa K Isaacson; Sofia Marques; Gunes Bozkurt; J Pedro Simas; Rudolph Jaenisch; Hidde L Ploegh
Journal:  Cell Rep       Date:  2012-04-26       Impact factor: 9.423

3.  Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections.

Authors:  Xiaoyan Zhan; Karen S Slobod; Sateesh Krishnamurthy; Laura E Luque; Toru Takimoto; Bart Jones; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2008-05-01       Impact factor: 3.641

4.  A recombinant Sendai virus is controlled by CD4+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  Scott A Brown; Julia L Hurwitz; Amy Zirkel; Sherri Surman; Toru Takimoto; Irina Alymova; Chris Coleclough; Allen Portner; Peter C Doherty; Karen S Slobod
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

5.  Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses.

Authors:  Kelly B McClellan; Shivaprakash Gangappa; Samuel H Speck; Herbert W Virgin
Journal:  PLoS Pathog       Date:  2006-06-23       Impact factor: 6.823

6.  Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection.

Authors:  Vaiva Vezys; David Masopust; Christopher C Kemball; Daniel L Barber; Leigh A O'Mara; Christian P Larsen; Thomas C Pearson; Rafi Ahmed; Aron E Lukacher
Journal:  J Exp Med       Date:  2006-09-11       Impact factor: 14.307

Review 7.  The virus-immunity ecosystem.

Authors:  P C Doherty; S J Turner
Journal:  Arch Virol Suppl       Date:  2005

8.  Extralymphatic virus sanctuaries as a consequence of potent T-cell activation.

Authors:  Mike Recher; Karl S Lang; Alexander Navarini; Lukas Hunziker; Philipp A Lang; Katja Fink; Stefan Freigang; Panco Georgiev; Lars Hangartner; Raphael Zellweger; Andreas Bergthaler; Ahmed N Hegazy; Bruno Eschli; Alexandre Theocharides; Lukas T Jeker; Doron Merkler; Bernhard Odermatt; Martin Hersberger; Hans Hengartner; Rolf M Zinkernagel
Journal:  Nat Med       Date:  2007-11-04       Impact factor: 53.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.